VIR BIOTECHNOLOGY INC's ticker is VIR and the CUSIP is 92764N102. A total of 144 filers reported holding VIR BIOTECHNOLOGY INC in Q4 2020. The put-call ratio across all filers is 1.24 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $77,968 | -54.0% | 8,321 | +20.3% | 0.00% | -50.0% |
| Q2 2023 | $169,649 | +25.6% | 6,916 | +19.2% | 0.01% | +20.0% |
| Q1 2023 | $135,036 | -20.2% | 5,803 | 0.0% | 0.01% | -28.6% |
| Q4 2022 | $169,215 | +62.7% | 5,803 | +6.7% | 0.01% | +40.0% |
| Q3 2022 | $104,000 | -24.6% | 5,439 | 0.0% | 0.01% | -16.7% |
| Q2 2022 | $138,000 | +14.0% | 5,439 | +15.4% | 0.01% | +50.0% |
| Q1 2022 | $121,000 | -38.6% | 4,713 | 0.0% | 0.00% | -42.9% |
| Q4 2021 | $197,000 | -3.9% | 4,713 | 0.0% | 0.01% | 0.0% |
| Q3 2021 | $205,000 | -8.1% | 4,713 | 0.0% | 0.01% | -12.5% |
| Q2 2021 | $223,000 | 0.0% | 4,713 | +8.1% | 0.01% | 0.0% |
| Q1 2021 | $223,000 | +82.8% | 4,358 | -4.6% | 0.01% | +33.3% |
| Q4 2020 | $122,000 | -22.3% | 4,566 | 0.0% | 0.01% | -14.3% |
| Q3 2020 | $157,000 | -6.5% | 4,566 | +11.6% | 0.01% | -12.5% |
| Q2 2020 | $168,000 | +700.0% | 4,090 | +559.7% | 0.01% | +700.0% |
| Q1 2020 | $21,000 | +162.5% | 620 | 0.0% | 0.00% | – |
| Q4 2019 | $8,000 | – | 620 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Bill & Melinda Gates Foundation | 1,559,142 | $36,281,234 | 32.04% |
| SB INVESTMENT ADVISERS (UK) LTD | 18,319,938 | $426,304,957 | 3.50% |
| Zebra Capital Management LLC | 27,110 | $631 | 3.15% |
| Avidity Partners Management LP | 1,640,200 | $38,167,454 | 1.27% |
| Sofinnova Investments, Inc. | 657,559 | $15,301,398 | 0.98% |
| DCF Advisers, LLC | 62,000 | $1,442,740 | 0.88% |
| SECTOR GAMMA AS | 145,545 | $3,386,832 | 0.82% |
| Temasek Holdings (Private) Ltd | 5,814,972 | $135,314,398 | 0.80% |
| BRAIDWELL LP | 604,036 | $14,055,918 | 0.46% |
| SummerHaven Investment Management, LLC | 26,045 | $606,067 | 0.35% |